SBS On the Money: CEO SERIES: ResMed reports as the ASX plunges

Medical device maker Resmed reports its earnings and signals potential partnerships with big tech. Rhayna Bosch talks to ResMed CEO Mick Farrell. Meanwhile – global share markets come crashing down – and Mahjabeen Zaman, the head of FX Researxch at ANZ Babnk says the ASX200 is clocking its WORST single trading day in 16 months.

Om Podcasten

Hear the story behind the headlines. In under ten minutes each episode, we’ll help you make sense of the news stories that matter to you from Australia and the world, with reports and interviews from the SBS News team.